Sessa Capital Im, L.P. Chimerix Inc Transaction History

Sessa Capital Im, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $106,702 - $185,776	-47,635 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.58 - $4.9 $1.46 Million - $2 Million	-408,708 Reduced 89.56%	47,635 $185,000
Q2 2018 Aug 14, 2018	SELL	$4.43 - $5.14 $2.14 Million - $2.49 Million	-483,948 Reduced 51.47%	456,343 $2.17 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $4.09 Million - $4.94 Million	940,291	940,291 $4.94 Million

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

Stay updated on Sessa Capital Im, L.P. with notifications on news.